Find all the latest information in lymphoma and CLL, arranged by subtype and malignancy.
Mosunetuzumab in heavily pretreated follicular lymphoma: Phase I dose-escalation trial updates
During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma Hub...
What factors should be considered when sequencing therapy in R/R follicular lymphoma?
During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma Hub spoke to...
Acalabrutinib meets primary endpoint in ELEVATE-RR trial for patients with R/R CLL
On January 25, 2021, it was announced that acalabrutinib has met its primary endpoint of non-inferior...
5-year results of the MURANO phase III trial of venetoclax + rituximab vs bendamustine + rituximab in patients with CLL
During the 62nd American Society of Hematology (ASH) Annual Meeting and...
CFT7455 receives clearance of Investigational New Drug Application by FDA for the treatment of multiple myeloma and non-Hodgkin lymphoma
The U.S. Food and Drug Administration (FDA) announced the...
What novel therapies are showing promise for patients with heavily pretreated MCL?
During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma Hub spoke to Michael...
How effective is nivolumab + brentuximab vedotin as a consolidation therapy for Hodgkin lymphoma?
EMA grants PRIME designation to anti-CD30 CAR-T cell therapy for the treatment of patients with R/R cHL
On January 18, 2021, it was announced that the European Medicines Agency (EMA) granted Priority...
Aggressive B-cell lymphomas
ALK-positive large B-cell lymphoma
Diffuse large B-cell lymphoma
Epstein-Barr virus-positive diffuse large B-cell lymphoma
Germinal center B-cell-like
Gray zone lymphoma
High-grade B-cell lymphoma
High-grade B-cell lymphoma – double hit lymphoma
Intravascular large B-cell lymphoma
Primary cutaneous DLBCL, leg type
Primary DLBCL of the central nervous system
Primary mediastinal large B-cell lymphoma
Transformed follicular lymphoma
Classical Hodgkin lymphoma
Hodgkin lymphoma, not otherwise specified
Mixed cellularity classical Hodgkin lymphoma
Nodular lymphocyte-predominant Hodgkin lymphoma
Nodular sclerosis classical Hodgkin lymphoma
Indolent B-cell lymphomas
Hairy cell leukemia
Hairy cell leukemia variant
In situ follicular neoplasia
Marginal zone lymphoma
Nodal marginal zone lymphoma
Pediatric-type follicular lymphoma, pediatric-type nodal follicular lymphoma
Primary cutaneous marginal zone lymphoma
Splenic marginal zone lymphoma
Mantle cell lymphomas
In situ mantle cell neoplasia
Mantle cell lymphoma
Mature T and NK cell neoplasms
Adult T-cell leukemia/lymphoma
Aggressive NK-cell leukemia
Anaplastic large cell lymphoma, ALK-negative
Anaplastic large cell lymphoma, ALK-positive
Angioimmunoblastic T-cell lymphoma
Breast implant-associated anaplastic large cell lymphoma
Cutaneous T-cell lymphoma
Enteropathy-associated T-cell lymphoma
Epstein-Barr virus-positive T-cell lymphoma
Extranodal NK/T-cell lymphoma, nasal type
Follicular T-cell lymphoma
Hepatosplenic T-cell lymphoma
Monomorphic epitheliotropic intestinal T-cell lymphoma
Nodal peripheral T-cell lymphoma with TFH phenotype
Peripheral T-cell lymphoma
Primary cutaneous acral CD8+ T-cell lymphoma
Primary cutaneous anaplastic large cell lymphoma
Primary cutaneous CD30+ T-cell lymphoproliferative disorders
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder
Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma
Subcutaneous panniculitis-like T-cell lymphoma
T-cell prolymphocytic leukemia
Monoclonal B-cell lymphocytosis
Chronic lymphocytic leukemia
Small lymphocytic lymphoma
Classical Hodgkin lymphoma post-transplant lymphoproliferative disorders
Post-transplant lymphoproliferative disorders